Consequently, the number of SMN2 genes and their expression levels are directly linked to SMA clinical severity, classified from the most severe type 1 to the mild form type 3, based on the age of onset and on disease progression (Harding and Thomas, 1980). Here, SMN2 is linked to proximal spinal muscular atrophy.